CYCLOSERINE
- Product NDC
- 13845-1201
- 11-digit product format
- 138451201
- Labeler code
- 13845
- Product ID
- 13845-1201_1d21c18e-a54d-4c62-9c3b-ee0912a50950
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CYCLOSERINE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Parsolex Gmp Center, Inc.
- Application
- ANDA060593
- Marketing category
- ANDA
- Marketing start
- 2009-03-01
- Marketing end
- 0000-00-00
- Substance
- CYCLOSERINE
- Active strength
- 250 mg/250mg
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 13845-1201-1 | CYCLOSERINE | 250 mg in 1 CAPSULE | CAPSULE | 250 | | 5 |
| 13845-1201-3 | CYCLOSERINE | 40 in 1 BOTTLE | CAPSULE | 40 | | 5 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 13845-1201 | CYCLOSERINE CAPSULE [PARSOLEX GMP CENTER, INC.] | 5 | Legacy NDC, 2 package rows | 20230120_10727aa8-a03e-4b61-9a80-a024cb4a2d28.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 13845-1201-1 | 13845120101 | 250 mg in 1 CAPSULE | 250 mg | | | | | Historical |
| 13845-1201-3 | 13845120103 | 40 CAPSULE in 1 BOTTLE (13845-1201-3) > 250 mg in 1 CAPSULE (13845-1201-1) | 40 capsule | 2009-03-01 | 0000-00-00 | No | No | Current |